Stem Cells
Therapies
Stem Cells Therapies
The purpose of banking stem cells is to apply them in the therapy. For the first time cord blood was used in 1988 and since then according to publicly available statistics it has been used over 85 000 times worldwide (including statistics of China).
FamiCord Group stores over 1,000,000 samples of cells of different types and has supplied stem cells for application in clinic for more than 7000 patients. We supply stem cells for standard transplantations (cord blood , bone marrow and mobilized peripheral blood) and cellular therapies. On top of that we provide cell based products in GMP standard for clinical trials.
Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, including haematological, neurological, ophthalmological, orthopaedical, dermatological disorders.
Check the full list of patients who received stem cell therapy derived from FamiCord labs.
List last update: 06.2026
List of patients who received stem cells from FamiCord Group laboratories
| Lp. | Source | Source type | Diagnosis | Medical field | Year of application | Therapy | Country | Age of recipient |
|---|---|---|---|---|---|---|---|---|
| 2801 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 23 |
| 2802 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 36 |
| 2803 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 17 |
| 2804 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 63 |
| 2805 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 63 |
| 2806 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 12 |
| 2807 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 16 |
| 2808 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 58 |
| 2809 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
| 2810 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 25 |
| 2811 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 30 |
| 2812 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
| 2813 | Bone Marrow | Allogeneic | Adenosine Deaminase Deficient Severe Combined Immunodeficiency (Ada-Scid) | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 2814 | Bone Marrow | Allogeneic | Amyloidosis | Hematology | 2022 | Standard Therapy | Poland | 9 |
| 2815 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 19 |
| 2816 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 49 |
| 2817 | Bone Marrow | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 10 |
| 2818 | Bone Marrow | Allogeneic | Bone Marrow Failure Syndrome | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 2819 | Bone Marrow | Allogeneic | Chediak-Higashi-Syndrome | Hematology | 2022 | Standard Therapy | Poland | 10 |
| 2820 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2022 | Standard Therapy | Poland | 37 |
| 2821 | Bone Marrow | Allogeneic | Combined Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 7 |
| 2822 | Bone Marrow | Allogeneic | Common Variable Immunodeficiency With Granulomatous-Lymphocytic Interstitial Lung Disease | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 2823 | Bone Marrow | Allogeneic | Diamond Blackfan Anemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 2824 | Bone Marrow | Allogeneic | Diamond Blackfan Anemia | Hematology | 2022 | Standard Therapy | Poland | 4 |
| 2825 | Bone Marrow | Allogeneic | Dock8 Deficiency | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 2826 | Bone Marrow | Allogeneic | Early Isolated All Bm Relapse | Hematology | 2022 | Standard Therapy | Poland | 6 |
| 2827 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2022 | Standard Therapy | Poland | 5 |
| 2828 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2022 | Standard Therapy | Poland | 7 |
| 2829 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2022 | Standard Therapy | Poland | 16 |
| 2830 | Bone Marrow | Allogeneic | Griscelli Syndrome Type 2 | Hematology | 2022 | Standard Therapy | Poland | 2 |
| 2831 | Bone Marrow | Allogeneic | Hemophagocytic Lymphocytosis | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 2832 | Bone Marrow | Allogeneic | Hemophagocytic Lymphohistiocytosis (Hlh) | Hematology | 2022 | Standard Therapy | Poland | 46 |
| 2833 | Bone Marrow | Allogeneic | Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 57 |
| 2834 | Bone Marrow | Allogeneic | Infant Acute Lymphoblastic Leukemia With Kmt2a Gene Rearrangement | Hematology | 2022 | Standard Therapy | Poland | 7 |
| 2835 | Bone Marrow | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 2836 | Bone Marrow | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 2837 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 49 |
| 2838 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 16 |
| 2839 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 63 |
| 2840 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 2841 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 14 |
| 2842 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 15 |
| 2843 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 51 |
| 2844 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 8 |
| 2845 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 12 |
| 2846 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 65 |
| 2847 | Bone Marrow | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 56 |
| 2848 | Bone Marrow | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 17 |
| 2849 | Bone Marrow | Allogeneic | Nhl (Non-Hodgkin’s Lymphoma) | Hematology | 2022 | Standard Therapy | Poland | 37 |
| 2850 | Bone Marrow | Allogeneic | Nijmegen Breakage Syndrome | Hematology | 2022 | Standard Therapy | Poland | 9 |
| 2851 | Bone Marrow | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 13 |
| 2852 | Bone Marrow | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 2853 | Bone Marrow | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 2854 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 53 |
| 2855 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 37 |
| 2856 | Bone Marrow | Allogeneic | Osteopetrosis | Hematology | 2022 | Standard Therapy | Poland | 2 |
| 2857 | Bone Marrow | Allogeneic | Other Immune System Disorders | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 2858 | Bone Marrow | Allogeneic | Other Non-Malignant Disease | Hematology | 2022 | Standard Therapy | Poland | 8 |
| 2859 | Bone Marrow | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria (Pnh) | Hematology | 2022 | Standard Therapy | Poland | 17 |
| 2860 | Bone Marrow | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria With Marrow Failure | Hematology | 2022 | Standard Therapy | Poland | 10 |
| 2861 | Bone Marrow | Allogeneic | Philadelphia-Positive Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
| 2862 | Bone Marrow | Allogeneic | Pre-B Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 32 |
| 2863 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 2864 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 9 |
| 2865 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 46 |
| 2866 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 6 |
| 2867 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 15 |
| 2868 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 65 |
| 2869 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 12 |
| 2870 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
| 2871 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 15 |
| 2872 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
| 2873 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 2874 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 19 |
| 2875 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 6 |
| 2876 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 2877 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 35 |
| 2878 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 2879 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 5 |
| 2880 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 30 |
| 2881 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 14 |
| 2882 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 49 |
| 2883 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 2884 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 2 |
| 2885 | Bone Marrow | Allogeneic | Shwachman-Diamond Syndrome – Sds | Hematology | 2022 | Standard Therapy | Poland | 7 |
| 2886 | Bone Marrow | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 2887 | Bone Marrow | Allogeneic | Very Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 16 |
| 2888 | Bone Marrow | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 2889 | Bone Marrow | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 2890 | Bone Marrow | Allogeneic | X-Linked Congenital Dyskeratosis | Hematology | 2022 | Standard Therapy | Poland | 2 |
| 2891 | Apheresis | Allogeneic | Acute Biphenotypic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 22 |
| 2892 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 41 |
| 2893 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 55 |
| 2894 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 4 |
| 2895 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 29 |
| 2896 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 59 |
| 2897 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 9 |
| 2898 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 57 |
| 2899 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 24 |
| 2900 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 36 |